NovMetaPharma Co., Ltd. (XKON:229500)
South Korea · Delayed Price · Currency is KRW 8,750.00
+760.00 (9.51%)
At close: May 14, 2026
NovMetaPharma Market Cap
NovMetaPharma has a market cap or net worth of 112.36 billion as of May 15, 2026. Its market cap has increased by 7.63% in one year.
Market Cap
112.36B
Enterprise Value
n/a
Revenue
1.30B
Ranking
n/a
PE Ratio
72.92
Stock Price
8,750.00
Market Cap Chart
Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 112.36B, an increase of 50.64%. That is a compound annual growth rate of 4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 112.36B | -31.36% |
| Dec 30, 2025 | 163.69B | 187.16% |
| Dec 30, 2024 | 57.00B | -46.33% |
| Dec 29, 2022 | 106.21B | -45.89% |
| Dec 30, 2021 | 196.29B | -9.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Biologics | 159.78B |
| QuadMedicine | 131.36B |
| Cell Biotech | 117.65B |
| BIO-FD&C | 113.48B |
| CHA Vaccine Research Institute | 99.67B |
| Choong Ang Vaccine Laboratory | 95.82B |
| TegoScience | 92.56B |
| SunBio,Inc. | 92.55B |